Understanding the costs of drug-related actions is an important aspect of drug policy. Some of the funds allocated by governments for expenditure to tasks related to drugs are identified as such in the budget (‘labelled’). Often, however, the majority of drug-related expenditure is not identified (‘unlabelled’) and must be estimated by modelling approaches.
The Finnish government approves an annual drug budget that is in line with its drug strategy and action plan. Annual estimates of expenditures are also provided and include both labelled and unlabelled expenditures. The most recent available data on public expenditure in Finland are for 2013, when total drug-related expenditure represented 0.2 % of gross domestic product (GDP), which was approximately EUR 412 000. Of this, 62 % was spent on public order and safety, 25 % on social protection and 13 % on healthcare.
In 2013, total drug-related public expenditure in Finland remained broadly unchanged in real terms (it increased by 1 %) compared with 2012; however, it increased by 2.4 % in nominal terms.
Public expenditure related to illicit drugs in Finland
NBBased on estimates of Finland’s direct expenditure for licit and illicit substances in 2013.